Profound Medical Corp. — Regulatory Filings 2019

Oct 18, 2019

8-A12B 1 tm1920528d1_8-a12b.htm FORM 8-A12B

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

Field: Rule-Page

Field: /Rule-Page

FORM 8-A

Field: Rule-Page

Field: /Rule-Page

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR (g) OF THE

SECURITIES EXCHANGE ACT OF l934

Field: Rule-Page

Field: /Rule-Page

Profound Medical Corp.

(Exact name of Registrant as specified in its charter)

Field: Rule-Page

Field: /Rule-Page

Ontario, Canada	NOT APPLICABLE
(State of incorporation or organization)	(I.R.S. Employer Identification No.)

2400 Skymark Avenue, Unit 6, Mississauga, Ontario	L4W 5K5
(Address of principal executive offices)	(Zip Code)

Securities to be registered pursuant to Section 12(b) of the Act:

Title of each class to be so registered	Name of each exchange on which each class is to be registered
Common Shares	The Nasdaq Stock Market LLC

Field: Rule-Page

Field: /Rule-Page

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), please check the following box. x

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box. ¨

Securities Act registration statement file number to which this form relates: 333-233997

Securities to be registered pursuant to Section 12(g) of the Act:

None

(Title of Class)

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

INFORMATION REQUIRED IN REGISTRATION STATEMENT

Item 1. Description of Registrant’s Securities to be Registered.

The securities to be registered consist of common shares, no par value (“Common Shares”) of Profound Medical Corp. (the “Registrant”). The description of the Registrant’s Common Shares under the section captioned “Description of Securities” in the prospectus included in the Registrant’s registration statement on Form F-10 (File No. 333-233997) (the “Registration Statement”), initially filed with the Securities and Exchange Commission on September 27, 2019, as subsequently amended by any amendments to such Registration Statement, is incorporated herein by reference.

Item 2. Exhibits.

Under the “Instructions as to Exhibits” section of Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are to be registered on The Nasdaq Stock Market LLC and the securities to be registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

Field: Page; Sequence: 2

Field: /Page

SIGNATURE

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized, in the City of Mississauga, Province of Ontario, Canada on October 18, 2019.

PROFOUND MEDICAL CORP.
By:	/s/ Aaron Davidson
	Name: Aaron Davidson Title: Chief Financial Officer

Field: Page; Sequence: 3; Options: Last

Field: /Page